Watson Pharmaceuticals
Watson Pharmaceuticals appears in FDA public data with 1 recall, 0 510(k) clearances, 2 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-145-2013, Class II) was initiated on December 18, 2012.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 2
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-145-2013 | Class II | Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per b | December 18, 2012 |